Orkla India IPO Allotment Out! Check GMP, Step-by-Step Allotment Guide & Listing Details
Orkla India IPO Allotment:The Orkla India IPO allotment has been finalised today, on November 3, 2025, following an impressive investor turnout across all categories. The issue, open from October 29 to 31, witnessed robust retail and institutional participation, reflecting strong confidence in the MTR Foods parent’s growth story.

With the listing date set for November 6 on both the NSE and BSE, market buzz around the grey market premium (GMP) has kept investor sentiment upbeat. As per the latest market reports, Orkla India IPO GMP is hovering around ₹95, indicating a possible listing gain of nearly 13% over the issue price.
How to Check Orkla India IPO Allotment Status Online?
Investors can check their Orkla India IPO allotment status online through three official channels — BSE, NSE, and Kfin Technologies (the IPO registrar). Here’s a step-by-step guide:
🔹 Through BSE Website:
- Visit the BSE Allotment Page.
- Select ‘Equity’ under Issue Type.
- Choose ‘Orkla India Limited’ from the dropdown.
- Enter your Application Number or PAN.
- Verify using the captcha and click Search to view your allotment result.
🔹 Through NSE Website:
- Go to NSE IPO Allotment Page.
- Select ‘Equity and SME IPO Bids’.
- Choose ‘Orkla India Limited’.
- Enter your PAN and Application Number.
- Submit to check your allotment status.
🔹 Through Kfin Technologies (Registrar):
- Visit Kfin IPO Status Portal.
- Select ‘Orkla India Limited’ from the dropdown.
- Choose Application No, Demat Account, or PAN.
- Enter the required details and captcha.
- Click Submit to view your allotment status.
Once the basis of Orkla India IPO allotment is finalised, shares will be credited on November 4, while refunds to unsuccessful bidders will also be processed the same day.
How Strong Was Orkla India IPO Subscription?
Orkla India’s public issue witnessed a massive oversubscription across all categories. The company aimed to raise ₹1,667.54 crore through a complete offer-for-sale (OFS) of 2.28 crore equity shares at a price band of ₹695–₹730 per share.
| Investor Category | Subscription (Times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 117.63x |
| Non-Institutional Investors (NIIs) | 54.42x |
| Retail Individual Investors (RIIs) | 7.05x |
| Total Subscription | 48.73x |
(Source: NSE Data)
Such a stellar subscription mirrors the strong brand equity of Orkla India, which owns iconic food brands like MTR Foods. Analysts say the robust QIB demand reflects long-term institutional confidence in India’s fast-growing packaged foods market.
What Does Orkla India’s GMP Indicate?
The Orkla India IPO GMP (Grey Market Premium) has shown a steady uptrend this week, currently trading around ₹95. This suggests that the IPO may list at around ₹825-₹830, translating into approx. 13% listing gains over the upper price band.
| Date | IPO GMP (₹) | Trend | Expected Listing Gain |
|---|---|---|---|
| Nov 03 | ₹95 | Up | 13.08% |
| Nov 02 | ₹92 | Flat | 12.72% |
| Nov 01 | ₹92 | Up | 12.60% |
| Oct 31 | ₹71 | Flat | 10.1% |
| Oct 30 | ₹68 | Slight Down | 8.5% |
| Oct 29 | ₹75 | Up | 10.2% |
| Oct 28 | ₹70 | Stable | 9.6% |
While GMPs are unofficial and speculative, they often reflect investor sentiment ahead of listing. Analysts caution that actual listing performance will depend on market conditions and institutional buying on debut day.
Key IPO Highlights
| Particulars | Details |
|---|---|
| IPO Size | ₹1,667.54 crore |
| Price Band | ₹695–₹730 per share |
| Issue Type | 100% Offer-for-Sale |
| IPO Dates | Oct 29–31, 2025 |
| Allotment Date | Nov 3, 2025 |
| Refunds & Share Credit | Nov 4, 2025 |
| Listing Date | Nov 6, 2025 |
| Registrar | Kfin Technologies Ltd |
| Lead Manager | ICICI Securities Ltd |
This article is based on verified data from NSE filings and Kfin Technologies. Investors are encouraged to check official websites for real-time updates before trading decisions.
Final Takeaway: What Should Investors Expect Next?
With the Orkla India IPO allotment date around the corner, investors are eagerly awaiting the allotment results to be published by November 3. Successful applicants can expect shares in their demat accounts by November 4, followed by a possible listing premium on November 6.
Given the solid fundamentals, consistent brand performance, and strong QIB interest, the Orkla India IPO is being viewed as one of this season’s most promising listings on Dalal Street.
However, market participants are advised to track post-listing movement and broader market volatility before taking any short-term trading calls.
Orkla India IPO Frequently Asked Questions (FAQs)
1. When will the Orkla India IPO allotment be finalised?
The Orkla India IPO allotment will be finalised on November 3, 2025.
2. How can I check the Orkla India IPO allotment status?
You can check it via the Kfin Technologies, BSE or NSE website, or your demat account.
3. What is the expected listing price of Orkla India IPO?
The expected listing price is around ₹825 per share, based on a GMP of ₹95.
4. What are the allotment chances for retail investors?
Retail allotment chances are approximately 1 in 33 applications due to heavy oversubscription.
5. When will shares be credited to demat accounts?
Shares will be credited to demat accounts by November 4, 2025.
6. When is the Orkla India IPO listing date?
The shares will list on NSE and BSE on November 6, 2025.
7. When will the Orkla India IPO open and close?
The IPO opens on October 29, 2025, and closes on October 31, 2025.
8. How can investors apply through other brokers or banks?
Investors can apply via ASBA or UPI through brokers like Upstox, 5Paisa, or banks like HDFC, SBI, and ICICI.
9. When is the Orkla India IPO listing date?
Orkla India IPO listing date is on Nov 6, 2025.
10. What is Orkla India IPO GMP today (Grey Market Premium)?
Current GMP is ₹95, indicating strong investor sentiment and potential listing gains.
Click Here to know more market & IPO related news and updates.
Disclaimer: The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.



